Home › Funds › Rock Springs Capital Management LP › ELVN

Rock Springs Capital Management LP position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Rock Springs Capital Management LP reported holding 393,659 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$18.0M, representing 0.98% of its reported portfolio and ranking #34 among its reported holdings. Rock Springs Capital Management LP has disclosed ELVN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)393.66K sh
Reported value held$18.05M
Portfolio Weight0.98%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's ELVN position evolved

Rock Springs Capital Management LP first disclosed a stake in ELVN in Q1 2024 at 428,571 shares (US$7.5M). The position peaked in Q1 2026 at 826,500 shares, worth US$32.4M. Across 11 filings, Rock Springs Capital Management LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 393,659 shares valued at US$18.0M — a reduction of -70,966 shares quarter over quarter.. Notable position changes include a 51% increase in Q2 2025 (shares rose 2% over the following quarter), a 44% trim in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 428.57K $7.54M New
Q2 2024 428.57K $10.02M Hold
Q3 2024 428.57K $10.95M Hold
Q4 2024 428.57K $9.64M Hold
Q1 2025 465.87K $9.17M Add
Q2 2025 701.41K $14.07M Add
Q3 2025 686.11K $14.04M Reduce
Q4 2025 798.40K $12.30M Add
Q1 2026 826.50K $32.40M Add
Q2 2026 464.62K $23.58M Reduce
Q3 2026 393.66K $18.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$294.5M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Rock Springs Capital Management LP held ELVN?

Rock Springs Capital Management LP has disclosed ELVN holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Rock Springs Capital Management LP's current position in ELVN?

As of Q3 2026, Rock Springs Capital Management LP holds 393.66K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $18.05M, representing 0.98% of its reported portfolio and ranking #34.

Has Rock Springs Capital Management LP been buying or selling ELVN?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in ELVN. The position peaked in Q1 2026 at 826.50K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.